Matches in Nanopublications for { ?s ?p "[Moreover, as few as 1,000 CD133(+) MRTK cells initiated tumor development in nonobese diabetic/severe combined immunodeficient mice by 21 days (60-100%) in all examined cell lines, although the same number of CD133(-) MRTK cells could not form tumors (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion description "[Moreover, as few as 1,000 CD133(+) MRTK cells initiated tumor development in nonobese diabetic/severe combined immunodeficient mice by 21 days (60-100%) in all examined cell lines, although the same number of CD133(-) MRTK cells could not form tumors (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_provenance.
- NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion description "[Moreover, as few as 1,000 CD133(+) MRTK cells initiated tumor development in nonobese diabetic/severe combined immunodeficient mice by 21 days (60-100%) in all examined cell lines, although the same number of CD133(-) MRTK cells could not form tumors (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_provenance.
- assertion description "[Moreover, as few as 1,000 CD133(+) MRTK cells initiated tumor development in nonobese diabetic/severe combined immunodeficient mice by 21 days (60-100%) in all examined cell lines, although the same number of CD133(-) MRTK cells could not form tumors (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP733868.RARaVLm_5S02rGwR-uaSTCzP0rMHvPlsWD6Hr57kb35eg130_assertion description "[Moreover, as few as 1,000 CD133(+) MRTK cells initiated tumor development in nonobese diabetic/severe combined immunodeficient mice by 21 days (60-100%) in all examined cell lines, although the same number of CD133(-) MRTK cells could not form tumors (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733868.RARaVLm_5S02rGwR-uaSTCzP0rMHvPlsWD6Hr57kb35eg130_provenance.